Income statement revenue $200.41M (-1.3% YoY).Operating income $23.63M (-11.9% YoY).Pre-tax result $15.47M (-21.0% YoY).Net result $8.54M (-33.5% YoY).

Other Revenue: $3.88M (-15.0% YoY)
Pharma Manufacturer Solutions Revenues: $61.63M (+76.2% YoY)
Prescription Transactions Revenue: $106.39M (-25.6% YoY)
Subscription Revenue: $28.51M (+39.3% YoY)
Product development and technology: $26.71M (-10.8% YoY)
Sales and marketing: $81.99M (-3.4% YoY)
General and administrative: $24.81M (-12.6% YoY)
Depreciation and amortization: $22.27M (+12.9% YoY)
Other expense: $8.17M (+12.9% YoY)
Income tax expense: $6.93M (+2.9% YoY)

Loading financials

Income statement income statement flow. Revenue $200.41M. Net result $8.54M.

Income statement revenue $200.41M (-1.3% YoY).Operating income $23.63M (-11.9% YoY).Pre-tax result $15.47M (-21.0% YoY).Net result $8.54M (-33.5% YoY).

Other Revenue: $3.88M (-15.0% YoY)
Pharma Manufacturer Solutions Revenues: $61.63M (+76.2% YoY)
Prescription Transactions Revenue: $106.39M (-25.6% YoY)
Subscription Revenue: $28.51M (+39.3% YoY)
Product development and technology: $26.71M (-10.8% YoY)
Sales and marketing: $81.99M (-3.4% YoY)
General and administrative: $24.81M (-12.6% YoY)
Depreciation and amortization: $22.27M (+12.9% YoY)
Other expense: $8.17M (+12.9% YoY)
Income tax expense: $6.93M (+2.9% YoY)